| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Eyegate Pharmaceuticaals | 53,893 | 2,000 | 0.00% | ||
| 2 | MAST THERAPEUTICS INC | 369 | 17,000 | 0.00% | Put | |
| 3 | INTELLIPHARMACEUTICS INTL IN | 122 | 19,000 | 0.00% | Put | |
| 4 | INFINITY PHARMACEUTICALS INC | 167 | 22,000 | 0.00% | Call | |
| 5 | BENITEC BIOPHARMA LTD | 98,146 | 24,000 | 0.00% | ||
| 6 | INFINITY PHARMACEUTICALS INC COM | 22,500 | 30,000 | 0.00% | ||
| 7 | INFINITY PHARMACEUTICALS INC | 225 | 30,000 | 0.00% | Put | |
| 8 | RENNOVA HEALTH INC | 3,225,806 | 32,000 | 0.00% | ||
| 9 | PROVECTUS BIOPHARMACEUTICALS I | 93,283 | 35,000 | 0.00% | ||
| 10 | CombiMatrix Corp | 14,391 | 41,000 | 0.00% | ||
| 11 | TENAX THERAPEUTICS INC | 169 | 43,000 | 0.00% | Put | |
| 12 | NORTHWEST BIOTHERAPEUTICS IN | 813 | 47,000 | 0.00% | Put | |
| 13 | ATHERSYS INC | 225 | 49,000 | 0.00% | Put | |
| 14 | VIKING THERAPEUTICS INC | 176,113 | 51,000 | 0.00% | ||
| 15 | EDAP TMS S A | 157 | 52,000 | 0.00% | Put | |
| 16 | GALENA BIOPHARMA INC | 113,530 | 53,000 | 0.00% | ||
| 17 | ALLIQUA BIOMEDICAL INC | 483 | 54,000 | 0.00% | Call | |
| 18 | PROGENICS PHARMACEUTICALS IN | 130 | 55,000 | 0.00% | Put | |
| 19 | INVIVO THERAPEUTICS HLDGS CO | 100 | 58,000 | 0.00% | Call | |
| 20 | AKEBIA THERAPEUTICS INC | 100 | 75,000 | 0.00% | Call | |
| 21 | ALCOBRA LTD | 18,317 | 82,000 | 0.00% | ||
| 22 | TENAX THERAPEUTICS INC | 335 | 86,000 | 0.00% | Call | |
| 23 | DURECT CORP | 770 | 94,000 | 0.00% | Call | |
| 24 | NEWLINK GENETICS CORP | 162 | 97,000 | 0.01% | Put | |
| 25 | GALENA BIOPHARMA INC | 2,289 | 107,000 | 0.01% | Put | |
| 26 | ADVAXIS INC | 140 | 113,000 | 0.01% | Put | |
| 27 | ADVAXIS INC COM NEW | 14,000 | 113,000 | 0.01% | ||
| 28 | ARALEZ PHARMACEUTICALS INC | 413 | 136,000 | 0.01% | Call | |
| 29 | CLOVIS ONCOLOGY INC | 103 | 141,000 | 0.01% | Put | |
| 30 | REGULUS THERAPEUTICS INC | 49,231 | 142,000 | 0.01% | ||
| 31 | SERES THERAPEUTICS INC | 49 | 142,000 | 0.01% | Call | |
| 32 | PROGENICS PHARMACEUTICALS IN | 361 | 152,000 | 0.01% | Call | |
| 33 | RELYPSA INC | 88 | 163,000 | 0.01% | Put | |
| 34 | Zosano Pharma Corp | 128,600 | 170,000 | 0.01% | ||
| 35 | MOMENTA PHARMACEUTICALS INC | 159 | 172,000 | 0.01% | Put | |
| 36 | NATERA INC | 144 | 174,000 | 0.01% | Call | |
| 37 | ALCOBRA LTD | 409 | 184,000 | 0.01% | Put | |
| 38 | LIPOCINE INC NEW | 63,875 | 194,000 | 0.01% | ||
| 39 | ONCOBIOLOGICS INC - WARRANT B | 436,923 | 196,000 | 0.01% | ||
| 40 | ATHERSYS INC | 91,746 | 199,000 | 0.01% | ||
| 41 | CIDARA THERAPEUTICS INC | 20,277 | 209,000 | 0.01% | ||
| 42 | ONCOBIOLOGICS INC - WARRANT A | 426,184 | 209,000 | 0.01% | ||
| 43 | RELYPSA INC | 115 | 213,000 | 0.01% | Call | |
| 44 | STAFFING 360 SOLUTIONS INC | 136,583 | 216,000 | 0.01% | ||
| 45 | CELLECTAR BIOSCIENCES INC | 230,013 | 219,000 | 0.01% | ||
| 46 | TENET HEALTHCARE CORP | 81 | 224,000 | 0.01% | Call | |
| 47 | ARBUTUS BIOPHARMA CORP | 669 | 233,000 | 0.01% | Call | |
| 48 | AKARI THERAPEUTICS PLC | 17,428 | 235,000 | 0.01% | ||
| 49 | MEDICINES CO | 7,000 | 235,000 | 0.01% | ||
| 50 | AMARIN CORPORATION PLC | 1,118 | 241,000 | 0.01% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119067, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
